Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute
Status:
Completed
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
In this randomised trial, we hypothesised that mebeverine could enhance nocturnal continenece
of Orthotopic Bladder Substitute (OBS) patients by decreasing the frequency and reduce
maximum amplitude of uninhibited contractions of OBS ileum, and consequently it would
increase the OBS capacity